Mirum Pharmaceuticals (MIRM) Selling, General & Administrative (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -1.52 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 647.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | 96.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.33 Mn |
| Dec 31, 2025 | 74.13 Mn |
| Sep 30, 2025 | 61.91 Mn |
| Jun 30, 2025 | 63.29 Mn |
| Mar 31, 2025 | 57.71 Mn |
| Dec 31, 2024 | 56.83 Mn |
| Sep 30, 2024 | 50.55 Mn |
| Jun 30, 2024 | 49.21 Mn |
| Mar 31, 2024 | 45.64 Mn |
| Dec 31, 2023 | 46.18 Mn |
| Sep 30, 2023 | 36.53 Mn |
| Jun 30, 2023 | 32.95 Mn |
| Mar 31, 2023 | 30.22 Mn |
| Dec 31, 2022 | 26.47 Mn |
| Sep 30, 2022 | 22.51 Mn |
| Jun 30, 2022 | 20.97 Mn |
| Mar 31, 2022 | 19.12 Mn |
| Dec 31, 2021 | 19.04 Mn |
| Sep 30, 2021 | 17.35 Mn |
| Jun 30, 2021 | 13.35 Mn |
| Mar 31, 2021 | 9.48 Mn |
| Dec 31, 2020 | 7.23 Mn |
| Sep 30, 2020 | 5.73 Mn |
| Jun 30, 2020 | 5.04 Mn |
| Mar 31, 2020 | 4.69 Mn |
| Dec 31, 2019 | 4.28 Mn |
| Sep 30, 2019 | 3.71 Mn |
| Jun 30, 2019 | 2.45 Mn |
| Mar 31, 2019 | 1.32 Mn |